Literature DB >> 9155070

Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer.

E Touboul1, J P Lefranc, J Blondon, L Buffat, E Deniaud, Y Belkacémi, M Benmiloud, J Huart, A Laugier, M Schlienger.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate possibility of breast-conserving therapy and outcome for patients with locally advanced non-inflammatory breast cancer (LABC) and stage II >3 cm in diameter after primary chemotherapy (CT) followed by external preoperative irradiation (RT).
MATERIALS AND METHODS: Between 1982 and 1990, 147 patients were treated by four courses of induction CT (doxorubicin, vincristine, cyclophosphamide, 5-fluorouracil) followed by preoperative RT (45 Gy to the breast and nodal areas) and a fifth course of CT. Three different loco-regional approaches were proposed depending on tumour characteristics and tumour response. After completion of local therapy, all patients received a sixth course of CT and a maintenance adjuvant CT regimen without anthracycline.
RESULTS: Mastectomy and axillary dissection were performed in 52 patients, and conservative treatment in 95 patients (48 achieved complete remission and received additional radiation boost to initial tumour bed; 47 had a residual mass < or =3 cm in diameter and were treated by wide excision and axillary dissection followed by a boost to the excision site. Ten-year actuarial loco-regional failure rate was 20% after RT alone, 23% after wide excision and RT and 6% after mastectomy (P = 0.85). After multivariate analysis, possibility of breast-conserving therapy was related to initial tumour size. Ten-year overall survival rate was 66%; it was not influenced by local treatment (conservative vs. non-conservative local treatment, P = 0.89). However, local failure significantly decreased overall survival (P < 0.0001). After multivariate analysis, tumour response after induction CT and clinical stage had a significant impact on survival.
CONCLUSIONS: The present data indicate that induction CT followed by preoperative RT may permit the selection of some patients with LABC or stage II >3 cm for conservative treatment. The impact of this treatment modality on long term survival remains to be established.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155070     DOI: 10.1016/s0167-8140(97)01923-3

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

Review 1.  Local Recurrence after Breast-Conserving Surgery and Mastectomy Following Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer - a Meta-Analysis.

Authors:  Xiaodong Zhou; Yujie Li
Journal:  Breast Care (Basel)       Date:  2016-10-14       Impact factor: 2.860

2.  Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium.

Authors:  Konstantinos Papadimitriou; Konstantinos Papademetriou; Alexandros Ardavanis; Panteleimon Kountourakis
Journal:  J Thorac Dis       Date:  2010-09       Impact factor: 2.895

Review 3.  Function-preserving surgery for breast cancer.

Authors:  Hideo Inaji; Chiyomi Egawa; Yoshifumi Komoike; Kazuyoshi Motomura; Kinji Nishiyama; Tatsuki R Kataoka; Hiroki Koyama
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

4.  Breast conservation in locally advanced breast cancer.

Authors:  V Parmar; R A Badwe
Journal:  Indian J Surg Oncol       Date:  2010-08-07

5.  Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.

Authors:  William G Cance; Lisa A Carey; Benjamin F Calvo; Carolyn Sartor; Lynda Sawyer; Dominic T Moore; Julian Rosenman; David W Ollila; Mark Graham
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

6.  Locoregional recurrence of breast conserving surgery after preoperative chemotherapy in korean women with locally advanced breast cancer.

Authors:  Seeyoun Lee; Seok Won Kim; Seok-Ki Kim; Keun Seok Lee; Eun A Kim; Youngmee Kwon; Kyung Hwan Shin; Han-Sung Kang; Jungsil Ro; Eun Sook Lee
Journal:  J Breast Cancer       Date:  2011-12-27       Impact factor: 3.588

Review 7.  Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis.

Authors:  Xuan Li; Danian Dai; Bo Chen; Hailin Tang; Weidong Wei
Journal:  World J Surg Oncol       Date:  2017-11-28       Impact factor: 2.754

8.  Trends and outcomes of neoadjuvant radiotherapy compared with postoperative radiotherapy for malignant breast cancer.

Authors:  Wenyan Fu; Hefen Sun; Yang Zhao; Mengting Chen; Lipeng Yang; Shuiping Gao; Liangdong Li; Wei Jin
Journal:  Oncotarget       Date:  2018-05-11

Review 9.  A systematic review of neo-adjuvant radiotherapy in the treatment of breast cancer.

Authors:  Muneer Ahmed; Felix Jozsa; Michael Douek
Journal:  Ecancermedicalscience       Date:  2021-01-22

10.  Assessment of skin response in T4b breast carcinoma patients post-neoadjuvant chemotherapy.

Authors:  Abhishek Sharma; Shagun Mahajan; Sanjit Kumar Agrawal; Rosina Ahmed; Debdeep Dey
Journal:  Ecancermedicalscience       Date:  2021-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.